Peter Thal Larsen

@petertl.bsky.social

Global Editor, Reuters Breakingviews. Usual disclaimers apply. My free weekly newsletter: https://www.reuters.com/newsletters/the-week-in-breakingviews/

Will see if $BMY $AZN comes to anything, but combining two patent cliffs into one does not change the size of the cliff. Can get really big cost cuts but investors don’t tend to value these highly. To give an unfair example - Pfizer paid $160bn for Wyeth and Warner Lambert. Market cap now $140b